Futureproof 2026 · Vancouver
Simon Haworth
CEO · Intellomx
Where the model meets the lab.
Simon Haworth used an iceberg to show the distance between what a search can find in the literature and what a researcher still has to learn.
Read Kris Krüg’s recapLeave room for the experiment.
Simon described where his company uses computational tools and where its process still needs physical validation. The boundary matters more than a promise of speed.
Read the full recapSimon at Futureproof 2026
Festival photo album 5
Michelle Diamond / Diamond’s Edge PhotographyAbout Simon Haworth
Simon Haworth is CEO of Intellomx, a UK drug discovery company that uses its own neural network models to find the drivers of disease in raw gene and protein data. The company starts from what the biology measures and says flatly that it is not an LLM literature-mining engine. It has run target discovery collaborations with Janssen on blood cancers and, in 2025, with Johnson & Johnson on lung cancer. A British entrepreneur now based in Vancouver, Simon has founded or co-founded 19 companies, including the listed investment company IPSO Ventures, and started the BC + AI Life Sciences group. His case for AI in medicine is augmentation: tools that help people do what they could never do before.
2026 program record
- Thursday · October 291:45–2:05 PM
H.R. MacMillan Space Centre
1100 Chestnut St, Vancouver, BC V6J 3J9
- Thursday · October 292:25–2:35 PM
H.R. MacMillan Space Centre
1100 Chestnut St, Vancouver, BC V6J 3J9
Questions with the speakers
On stage with Dean Shev.
Times shown in Vancouver time. See the full program
Start here
Read
AI: Vive la Revolution!
His 2021 OBN cover story making the case for AI that augments people, with a lung cancer target program as the proof.
Read
Second collaboration with Johnson & Johnson
Intellomx’s 2025 follow-on deal with J&J to find and test new lung cancer targets.
Read
Revealing Causal Biology to Transform Drug Discovery
The company’s 2026 case for starting from causal biology in patient data, with LLMs kept as helpers, never as the biology engine.
Save, share and explore
Share the session
Where the Hype Runs Out in Drug Discovery October 29, 2026
2026 speaker artwork
Explore more speakers
All 38 speaker profiles
Dean ShevThu 292:05–2:25 PMSame session: Q&A
Sev GeraskinThu 292:35–2:55 PMAlso explores Ethics
Kristen DelphosThu 292:55–3:15 PMAlso explores Ethics
Brett GaylorThu 293:45–4:05 PMAlso explores Education
Stephanie DickThu 294:05–4:25 PMAlso explores Education
Loki JorgensonThu 299:20–9:40 AMAlso explores Ethics
Saved speakers (0)
Saved in this browser. Your list does not register you for the festival.
Save a speaker to find their profile here.










